Trial record 1 of 177054 for:    ALL
Previous Study | Return to List | Next Study

Single Centre Study to Determine the Antibody Response to G17DT in Patients With Advanced Pancreatic Cancer.

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Cancer Advances Inc.
ClinicalTrials.gov Identifier:
NCT02098239
First received: March 25, 2014
Last updated: NA
Last verified: March 2014
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: May 2002
  Primary Completion Date: April 2002 (Final data collection date for primary outcome measure)